| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/17/2002 | US6451765 Methods for treating breast cancer using Mammastatin |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451759 Noncleavable Fas ligand |
| 09/17/2002 | US6451596 Helper adenovirus vectors |
| 09/17/2002 | US6451595 Murine leukemia virus with pol, env, and gag coding regions deleted; gene therapy; gene expression and engineering |
| 09/17/2002 | US6451594 Adenovirus vector comprising transgene, cardiomyocyte restricted ankyrin repeat protein promoter, and inverted terminal repeat sequences from human adeno-associated virus |
| 09/17/2002 | US6451593 Circular strand of dna forms dumbbell; complementary sequence duplex has promoter, coding, and polyadenylation sequences; noncomplementary single-strand loops; microprojectiles for ballistic cell transfer |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451571 Isolated nucleic acid molecules encoding a herpesviridae thymidine kinase enzyme comprising one or more mutations, at least one of the mutations encoding an amino acid substitution upstream from a drh nucleoside binding site which increases a |
| 09/17/2002 | US6451562 Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
| 09/17/2002 | US6451557 Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451549 Encoded by a polynucleotide; use as reporter molecule |
| 09/17/2002 | US6451539 Expression vectors, transfection systems, and method of use thereof |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451322 Retrovirus like particles made non infectious by a plurality of mutations |
| 09/17/2002 | US6451318 Secreted proteins |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451306 Specific protocol for use in grafting donor cells genetically modified to produce nerve growth factors into grafting sites within the cholinergic basal forebrain and is especially useful in treating neurodegenerative conditions such as |
| 09/17/2002 | US6451286 Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
| 09/17/2002 | US6451256 Recombinant viruses in frozen or liquid form, in which infectious viruses are preserved in an aqueous solution. the recombinant virus suspension comprises an aqueous sucrose solution at a concentration for gene therapy. |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2158427C Methods and compositions for controlling translation of hcv proteins |
| 09/17/2002 | CA2113118C Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
| 09/15/2002 | CA2373454A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070697A1 Mammalian nuclear receptor l67 and methods of use |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070692A2 Abca9 transporter and uses thereof |
| 09/12/2002 | WO2002070676A2 Use of protein histidine phosphatase |
| 09/12/2002 | WO2002070673A1 Concentration and lysis of adenovirus-infected cells in a single unit operations |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070004A2 Papillomavirus vaccines |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/12/2002 | WO2002069896A2 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 09/12/2002 | WO2002069840A2 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | WO2002069799A1 Method of predicting stroke evolution utilising mri |
| 09/12/2002 | WO2002069711A1 Gene therapy for neurological tissues |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002052274A3 Screening method based on tsap6 binding partners |
| 09/12/2002 | WO2002028997A3 Methods of isolating bipotent hepatic progenitor cells |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2001093914A3 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 09/12/2002 | WO2001092543A3 Improved methods of transfection |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001077151A3 Fdrg proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | WO2001068078A3 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001046384A3 A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
| 09/12/2002 | WO2001041814A9 Method of administering adenovirus |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001016168A9 Induction of programmed cell death by n5 gene |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | WO2001011009A3 Intestinal gene therapy |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | WO2000066176A9 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128222 Methods to enhance wound healing and enhanced wound coverage material |
| 09/12/2002 | US20020128221 Glycosyltransferase vectors for treating cancer |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128217 Therapeutic use of cis-element decoys in vivo |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128187 Novel nucleic acids and polypeptides |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020127721 Polypeptide for use in the treatment of cancer or genetic disorder |
| 09/12/2002 | US20020127715 Adjusting gene expression in preferential cells; obtain pluripotent cells, transform, monitor gene expression, compare to control, detect adjustment in gene expression |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127640 Pancreas-derived plasminogen activator inhibitor |